Bolt Biotherapeutics Inc. (BOLT) at a glance

Bolt Biotherapeutics Inc. (BOLT) is a micro-cap Healthcare company. It trades at $4.26, with a 0% profit margin and revenue decline of 97.9%. It does not pay a dividend. Vestovix scores it 35/100 overall. Its strongest dimension is Value (58/100) and its weakest is Growth (11/100). Its volatility is roughly in line with the market.

Price

$4.27

Market cap

$8.8M

P/E ratio

n/a

Dividend yield

None

Beta

1.13

52-week range

$3.75 to $7.20